TRODELVY Archives - BiomolBiomed Viewpoints

October 6, 2024

Latest posts

[ October 4, 2024 ] The Reviewer of the Month for October 2024: Roozbeh Heidarzadehpilehrood, MD, PhD Reviewer of the Month
[ October 1, 2024 ] Streptococcus anginosus: A New Pathogen in Gastritis and Gastric Cancer Author Summary
[ September 3, 2024 ] The Reviewer of the Month for September 2024: Malik Galijasevic, MD, PhD Reviewer of the Month
[ August 29, 2024 ] Neuromodulation guide for the non-neuromodulator clinician: What it is and how it can benefit patients? Author Summary
[ August 15, 2024 ] Pathology and Beyond: The Multifaceted Career of Dr. Ivan Damjanov Interview

New therapeutic option for the patients with metastatic triple-negative breast cancer: Sacituzumab govitecan-hziy

April 28, 2020 0

By Semir Vranic, MD, PhD Bosnian Journal of Basic Medical Sciences Editor in Chief Food and Drug Administration (FDA) has just granted accelerated approval to sacituzumab govitecan-hziy (TRODELVY, Immunomedics, Inc.) for the patients with metastatic […]